Retour

MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast)

Health Health

LA JOLLA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received an issue notification from the U.S. Patent and Trademark Office for a new patent which covers extended-release oral formulations of MN-166 (ibudilast). This new patent is expected to expire no earlier than September 2040. The allowed claims cover a formulation in the form of a tablet or capsule and cover a range of doses of MN-166 (ibudilast).

GlobeNewswire Inc. • 07/05/2024 à 12:00:00
Medicinova, Inc.
Address: 4275 EXECUTIVE SQUARE
Postal Code: 92037
City: LA JOLLA
State: CA
Phone Number: 858-373-1500
Website: https://www.medicinova.com
Status: Active
Company Info

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

List Date2006-12-07
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001226616
Composite figiBBG000RDP030
Share Class figiBBG001SNG8P4
Market Cap69,645,669 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees13
Share Class Shares Outstanding49050000
Weighted Shares Outstanding49046246
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
1.425
1.425
1.495
1.49
1.499
Variance
1.42%
-4.43%
1.01%
-0.67%
-2.35%
Open
1.405
1.491
1.48
1.5
1.535
Highest
1.435
1.491
1.495
1.649
1.535
Lowest
1.435
1.478
1.495
1.535
1.535
History
PeriodVarhighestlowest
1 week
-7.17%
1.535
1.435
1 month
2.52%
1.39
1.325
3 month
8.94%
1.355
1.306
6 month
-28.39%
2.16
1.2901
1 year
-32.46%
2.22
1.2901
3 year
-65.66%
4.26
1.2901
5 year
-86.94%
11
1.2901
10 year
-22.56%
1.87
1.2901
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-09 2023-11-09 UNPUB
Assets 71,132,845 68,718,642 68,136,561 UNPUB
Current Assets 56,034,398 53,521,735 52,996,147 UNPUB
Current Liabilities 2,715,422 2,821,236 2,801,679 UNPUB
Equity 67,726,252 65,175,929 64,669,252 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 67,726,252 65,175,929 64,669,252 UNPUB
Liabilities 3,406,593 3,542,713 3,467,309 UNPUB
Liabilities And Equity 71,132,845 68,718,642 68,136,561 UNPUB
Noncurrent Assets 15,098,447 15,196,907 15,140,414 UNPUB
Noncurrent Liabilities 691,171 721,477 665,630 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-09 2023-11-09 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 UNPUB
Net Cash Flow, Continuing 0 0 0 UNPUB
Net Cash Flow From Financing Activities -36,751,602 2,401,593 1,374,293 UNPUB
Net Cash Flow From Financing Activities, Continuing -36,751,602 2,401,593 1,374,293 UNPUB
Net Cash Flow From Investing Activities 39,929,015 -18,577 -2,744 UNPUB
Net Cash Flow From Investing Activities, Continuing 39,929,015 -18,577 -2,744 UNPUB
Net Cash Flow From Operating Activities -3,177,413 -2,383,016 -1,371,549 UNPUB
Net Cash Flow From Operating Activities, Continuing -3,177,413 -2,383,016 -1,371,549 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-09 2023-11-09 UNPUB
Comprehensive Income/Loss -2,919,046 -2,876,033 -725,819 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -2,919,046 -2,876,033 -725,819 UNPUB
Other Comprehensive Income/Loss -1,542 -2,876,033 -725,819 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-09 2023-11-09 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses UNPUB UNPUB 0 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB 2,146,888 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,917,504 -2,871,820 -723,107 UNPUB
Income/Loss From Continuing Operations Before Tax -2,917,504 -2,871,820 1,000,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,917,504 -2,871,820 -723,107 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -2,917,504 -2,871,820 -723,107 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -2,917,504 -2,871,820 -723,107 UNPUB
Operating Expenses 2,963,243 3,300,030 2,146,888 UNPUB
Operating Income/Loss -2,963,243 -3,300,030 -1,146,888 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 0 0 1,000,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-02-16
Assets 84,175,187 81,235,596 78,391,770 74,154,905
Current Assets 68,831,153 65,957,004 53,148,995 58,987,109
Current Liabilities 2,976,241 3,840,671 4,528,267 3,187,459
Equity 80,364,285 76,605,729 73,105,871 70,242,035
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 80,364,285 76,605,729 73,105,871 70,242,035
Liabilities 3,810,902 4,629,867 5,285,899 3,912,870
Liabilities And Equity 84,175,187 81,235,596 78,391,770 74,154,905
Noncurrent Assets 15,344,034 15,278,592 25,242,775 15,167,796
Noncurrent Liabilities 0 0 757,632 725,411
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-02-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -3,728,400 3,728,400 -18,896,599 -52,908,653
Net Cash Flow, Continuing -3,728,400 3,728,400 -18,896,599 -52,908,653
Net Cash Flow From Financing Activities UNPUB UNPUB 0 7,920
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 0 7,920
Net Cash Flow From Investing Activities UNPUB UNPUB -16,176,448 -40,005,010
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -16,176,448 -40,005,010
Net Cash Flow From Operating Activities -3,728,400 -2,455,968 -2,720,151 -12,911,563
Net Cash Flow From Operating Activities, Continuing -3,728,400 -2,455,968 -2,720,151 -12,911,563
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-02-16
Comprehensive Income/Loss -3,386,417 -4,028,998 -3,658,156 -14,085,491
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,393,852 -4,040,978 -3,658,156 -14,085,491
Other Comprehensive Income/Loss 0 0 -3,658,156 -16,408
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-10 2023-02-16
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share 0 0 0 0
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,386,417 -4,028,998 -3,652,184 -14,069,083
Income/Loss From Continuing Operations Before Tax -3,386,417 -4,028,998 -3,652,184 -14,066,261
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 2,822
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,386,417 -4,028,998 -3,652,184 -14,069,083
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,386,417 -4,028,998 -3,652,184 -14,069,083
Net Income/Loss Available To Common Stockholders, Basic -3,386,417 -4,028,998 -3,652,184 -14,069,083
Operating Expenses 3,410,012 4,089,935 3,897,467 14,628,649
Operating Income/Loss -3,410,012 -4,089,935 -3,897,467 -14,628,649
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-02-16
Assets 96,100,719 93,683,848 91,623,960 87,406,458
Current Assets 81,468,122 78,909,706 76,160,111 72,008,946
Current Liabilities 1,831,104 2,466,572 4,202,112 2,832,908
Equity 92,371,449 89,234,314 86,482,340 83,677,084
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 92,371,449 89,234,314 86,482,340 83,677,084
Liabilities 3,729,270 4,449,534 5,141,620 3,729,374
Liabilities And Equity 96,100,719 93,683,848 91,623,960 87,406,458
Noncurrent Assets 14,632,597 14,774,142 15,463,849 15,397,512
Noncurrent Liabilities 0 0 939,508 896,466
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-02-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 17,736,861 -2,768,950 11,367,644
Net Cash Flow, Continuing 0 17,736,861 -2,768,950 11,367,644
Net Cash Flow From Financing Activities 20,099,933 389,738 249,611 20,777,981
Net Cash Flow From Financing Activities, Continuing 20,099,933 389,738 249,611 20,777,981
Net Cash Flow From Investing Activities -16,245,981 16,220,187 -2,938 -28,732
Net Cash Flow From Investing Activities, Continuing -16,245,981 16,220,187 -2,938 -28,732
Net Cash Flow From Operating Activities -3,853,952 1,126,936 -3,015,623 -9,381,605
Net Cash Flow From Operating Activities, Continuing -3,853,952 1,126,936 -3,015,623 -9,381,605
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-02-16
Comprehensive Income/Loss -187,799 -4,284,141 -3,580,529 -10,144,910
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -194,620 -4,282,778 -3,580,529 -10,144,910
Other Comprehensive Income/Loss 0 0 -3,580,529 -10,658
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-12 2021-11-12 2022-02-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 4,187,799 4,284,141 0 14,169,184
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 4,187,799 4,284,141 3,639,439 14,169,184
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -187,799 -4,284,141 -3,579,167 -10,134,252
Income/Loss From Continuing Operations Before Tax -187,799 -4,284,141 37,500 -10,131,684
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 2,568
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -187,799 -4,284,141 -3,579,167 -10,134,252
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -187,799 -4,284,141 -3,579,167 -10,134,252
Net Income/Loss Available To Common Stockholders, Basic -187,799 -4,284,141 -3,579,167 -10,134,252
Operating Expenses 4,201,529 4,309,513 3,639,439 14,253,312
Operating Income/Loss -201,529 -4,309,513 -3,601,939 -10,215,812
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 4,000,000 0 37,500 4,037,500
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-23 2020-07-28 2020-10-26 2021-02-19
Assets 77,014,481 75,838,441 77,293,393 75,419,110
Current Assets 62,165,804 61,046,127 62,555,184 60,716,934
Current Liabilities 1,794,643 2,773,760 1,804,274 2,193,950
Equity 73,196,268 71,092,943 73,553,273 71,326,500
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 73,196,268 71,092,943 73,553,273 71,326,500
Liabilities 3,818,213 4,745,498 3,740,120 4,092,610
Liabilities And Equity 77,014,481 75,838,441 77,293,393 75,419,110
Noncurrent Assets 14,848,677 14,792,314 14,738,209 14,702,176
Noncurrent Liabilities 0 0 1,935,846 1,898,660
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-23 2020-07-28 2020-10-26 2021-02-19
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -2,462,270 -889,822 1,218,130 -3,757,095
Net Cash Flow, Continuing -2,462,270 -889,822 1,218,130 -3,757,095
Net Cash Flow From Financing Activities 418,946 1,200,745 5,127,418 7,105,759
Net Cash Flow From Financing Activities, Continuing 418,946 1,200,745 5,127,418 7,105,759
Net Cash Flow From Investing Activities -2,594 -10 -1,190 -36,492
Net Cash Flow From Investing Activities, Continuing -2,594 -10 -1,190 -36,492
Net Cash Flow From Operating Activities -2,878,622 -2,090,557 -3,908,098 -10,826,362
Net Cash Flow From Operating Activities, Continuing -2,878,622 -2,090,557 -3,908,098 -10,826,362
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-23 2020-07-28 2020-10-26 2021-02-19
Comprehensive Income/Loss -2,713,559 -4,451,229 -3,701,059 -13,849,435
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,713,679 -4,451,224 -3,701,059 -13,849,435
Other Comprehensive Income/Loss 0 0 -3,701,059 4,462
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-04-23 2020-07-28 2020-10-26 2021-02-19
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,713,559 -4,451,229 -3,703,820 -13,853,897
Income/Loss From Continuing Operations Before Tax -2,713,559 -4,451,229 -3,703,820 -13,855,545
Income Tax Expense/Benefit UNPUB UNPUB UNPUB -1,648
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,713,559 -4,451,229 -3,703,820 -13,853,897
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,713,559 -4,451,229 -3,703,820 -13,853,897
Net Income/Loss Available To Common Stockholders, Basic -2,713,559 -4,451,229 -3,703,820 -13,853,897
Operating Expenses 2,924,499 4,510,366 3,730,016 14,178,323
Operating Income/Loss -2,924,499 -4,510,366 -3,730,016 -14,178,323
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-04-25 2019-07-25 2019-10-24 2020-02-13
Assets 78,547,719 77,151,695 78,224,057 79,205,174
Current Assets 63,763,607 62,250,456 63,274,466 64,304,573
Current Liabilities 1,374,109 1,789,857 1,733,663 2,228,238
Equity 75,037,247 73,181,610 74,351,040 74,894,623
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 75,037,247 73,181,610 74,351,040 74,894,623
Liabilities 3,510,472 3,970,085 3,873,017 4,310,551
Liabilities And Equity 78,547,719 77,151,695 78,224,057 79,205,174
Noncurrent Assets 14,784,112 14,901,239 14,949,591 14,900,601
Noncurrent Liabilities 0 0 2,139,354 2,082,313
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-04-25 2019-07-25 2019-10-24 2020-02-13
Exchange Gains/Losses -1,617 2,178 -802 UNPUB
Net Cash Flow 896,245 -1,471,821 1,135,065 1,479,292
Net Cash Flow, Continuing 897,862 -1,473,999 1,135,867 1,479,292
Net Cash Flow From Financing Activities 3,929,105 180,371 3,174,872 10,615,551
Net Cash Flow From Financing Activities, Continuing 3,929,105 180,371 3,174,872 10,615,551
Net Cash Flow From Investing Activities -1,953 -2,060 0 -11,272
Net Cash Flow From Investing Activities, Continuing -1,953 -2,060 0 -11,272
Net Cash Flow From Operating Activities -3,029,290 -1,652,310 -2,039,005 -9,124,987
Net Cash Flow From Operating Activities, Continuing -3,029,290 -1,652,310 -2,039,005 -9,124,987
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-04-25 2019-07-25 2019-10-24 2020-02-13
Comprehensive Income/Loss -4,697,190 -3,881,876 -2,379,286 -12,941,189
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,698,971 -3,878,521 -2,379,286 -12,941,189
Other Comprehensive Income/Loss 0 0 -2,379,286 469
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-04-25 2019-07-25 2019-10-24 2020-02-13
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,697,190 -3,881,876 -2,378,504 -12,941,658
Income/Loss From Continuing Operations Before Tax -4,697,190 -3,881,876 -2,378,504 -12,928,998
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 12,660
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,697,190 -3,881,876 -2,378,504 -12,941,658
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,697,190 -3,881,876 -2,378,504 -12,941,658
Net Income/Loss Available To Common Stockholders, Basic -4,697,190 -3,881,876 -2,378,504 -12,941,658
Operating Expenses 4,979,359 4,182,021 2,645,565 14,031,077
Operating Income/Loss -4,979,359 -4,182,021 -2,645,565 -14,031,077
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-04-25 2018-07-23 2018-10-25 2019-02-13
Assets 78,664,744 79,076,687 77,275,331 77,222,692
Current Assets 63,571,877 64,605,800 62,810,806 62,758,360
Current Liabilities 1,198,982 1,568,145 1,804,514 2,191,914
Equity 75,569,807 75,588,903 73,551,771 73,107,612
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 75,569,807 75,588,903 73,551,771 73,107,612
Liabilities 3,094,937 3,487,784 3,723,560 4,115,080
Liabilities And Equity 78,664,744 79,076,687 77,275,331 77,222,692
Noncurrent Assets 15,092,867 14,470,887 14,464,525 14,464,332
Noncurrent Liabilities 1,895,955 1,919,639 1,919,046 1,923,166
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-04-25 2018-07-23 2018-10-25 2019-02-13
Exchange Gains/Losses 2,736 -1,756 7 691
Net Cash Flow 34,947,460 1,223,575 -1,720,412 34,321,675
Net Cash Flow, Continuing 34,944,724 1,225,331 -1,720,419 34,320,984
Net Cash Flow From Financing Activities 39,034,703 2,243,796 15,178 42,808,781
Net Cash Flow From Financing Activities, Continuing 39,034,703 2,243,796 15,178 42,808,781
Net Cash Flow From Investing Activities -8,584 634,901 0 626,324
Net Cash Flow From Investing Activities, Continuing -8,584 634,901 0 626,324
Net Cash Flow From Operating Activities -4,081,395 -1,653,366 -1,735,597 -9,114,121
Net Cash Flow From Operating Activities, Continuing -4,081,395 -1,653,366 -1,735,597 -9,114,121
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-04-25 2018-07-23 2018-10-25 2019-02-13
Comprehensive Income/Loss -4,543,000 -3,144,000 -6,780,000 -14,673,614
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,537,221 -3,148,152 -6,780,570 -14,673,614
Other Comprehensive Income/Loss 0 0 0 1,473
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-04-25 2018-07-23 2018-10-25 2019-02-13
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,543,000 -3,144,000 -6,780,000 -14,675,087
Income/Loss From Continuing Operations Before Tax -4,543,051 -3,142,232 -6,778,295 -14,669,811
Income Tax Expense/Benefit 0 1,907 1,663 5,276
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,543,000 -3,144,000 -6,780,000 -14,675,087
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,543,000 -3,144,000 -6,780,000 -14,675,087
Net Income/Loss Available To Common Stockholders, Basic -4,543,000 -3,144,000 -6,780,000 -14,675,087
Operating Expenses 4,667,000 3,400,000 7,028,000 15,586,826
Operating Income/Loss -4,666,581 -3,400,282 -7,027,714 -15,586,826
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-04-26 2017-07-26 2017-10-23 2018-02-13
Assets 37,424,345 38,456,323 40,107,564 43,419,064
Current Assets 22,324,344 23,362,881 25,010,167 28,328,323
Current Liabilities 1,021,952 1,419,891 1,737,729 2,880,969
Equity 32,751,432 33,386,269 34,719,672 38,642,140
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 32,751,432 33,386,269 34,719,672 38,642,140
Liabilities 4,672,913 5,070,054 5,387,892 4,776,924
Liabilities And Equity 37,424,345 38,456,323 40,107,564 43,419,064
Noncurrent Assets 15,100,001 15,093,442 15,097,397 15,090,741
Noncurrent Liabilities 3,650,961 3,650,163 3,650,163 1,895,955
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-04-26 2017-07-26 2017-10-23 2018-02-13
Exchange Gains/Losses 233 46 590 614
Net Cash Flow -2,480,881 1,252,891 1,645,380 3,873,706
Net Cash Flow, Continuing -2,481,114 1,252,845 1,644,790 3,873,092
Net Cash Flow From Financing Activities 66,157 2,664,093 3,564,225 10,797,026
Net Cash Flow From Financing Activities, Continuing 66,157 2,664,093 3,564,225 10,797,026
Net Cash Flow From Investing Activities 233 46 590 614
Net Cash Flow From Investing Activities, Continuing 233 46 590 614
Net Cash Flow From Operating Activities -2,547,271 -1,411,248 -1,919,435 -6,923,934
Net Cash Flow From Operating Activities, Continuing -2,547,271 -1,411,248 -1,919,435 -6,923,934
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-04-26 2017-07-26 2017-10-23 2018-02-13
Comprehensive Income/Loss -3,017 -2,789 -3,755 -11,161,759
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,014,808 -2,789,138 -3,754,592 -11,161,759
Other Comprehensive Income/Loss 0 0 0 -11,161,759
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-04-26 2017-07-26 2017-10-23 2018-02-13
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,017 -2,789 -3,755 -11,163,136
Income/Loss From Continuing Operations Before Tax -3,012,464 -2,786,607 -3,753,049 -12,907,186
Income Tax Expense/Benefit 4,060 2,030 2,054 -1,744,050
Interest Expense, Operating UNPUB UNPUB UNPUB 298
Net Income/Loss -3,017 -2,789 -3,755 -11,163,136
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,017 -2,789 -3,755 -11,163,136
Net Income/Loss Available To Common Stockholders, Basic -3,017 -2,789 -3,755 -11,163,136
Operating Expenses 3,024 2,805 3,792 13,027,093
Operating Income/Loss -3,023,522 -2,804,988 -3,791,536 -13,027,093
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-04-27 2016-07-26 2016-10-25 2017-02-14
Assets 43,858,557 42,363,286 40,777,871 39,813,134
Current Assets 28,687,496 27,221,351 25,611,997 24,703,847
Current Liabilities 1,049,796 1,333,371 1,375,055 1,630,075
Equity 39,140,143 37,372,729 35,745,817 34,531,929
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 39,140,143 37,372,729 35,745,817 34,531,929
Liabilities 4,718,414 4,990,557 5,032,054 5,281,205
Liabilities And Equity 43,858,557 42,363,286 40,777,871 39,813,134
Noncurrent Assets 15,171,061 15,141,935 15,165,874 15,109,287
Noncurrent Liabilities 3,668,618 3,657,186 3,656,999 3,651,130
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-04-27 2016-07-26 2016-10-25 2017-02-14
Exchange Gains/Losses 6,682 3,577 8,830 6,348
Net Cash Flow 5,541,644 -1,052,970 -1,593,621 2,041,288
Net Cash Flow, Continuing 5,534,962 -1,056,547 -1,602,451 2,034,940
Net Cash Flow From Financing Activities 7,976,333 440,306 13,788 8,665,636
Net Cash Flow From Financing Activities, Continuing 7,976,333 440,306 13,788 8,665,636
Net Cash Flow From Investing Activities -22,005 -11,129 -33,709 -84,483
Net Cash Flow From Investing Activities, Continuing -22,005 -11,129 -33,709 -84,483
Net Cash Flow From Operating Activities -2,419,366 -1,485,724 -1,582,530 -6,546,213
Net Cash Flow From Operating Activities, Continuing -2,419,366 -1,485,724 -1,582,530 -6,546,213
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-04-27 2016-07-26 2016-10-25 2017-02-14
Comprehensive Income/Loss -3,382 -3,199 -2,836 -10,859,214
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,371,891 -3,193,819 -2,833,214 -10,859,214
Other Comprehensive Income/Loss 0 0 0 -10,859,214
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-04-27 2016-07-26 2016-10-25 2017-02-14
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,382 -3,199 -2,836 -10,865,979
Income/Loss From Continuing Operations Before Tax -3,380,093 -3,198,310 -2,834,137 -10,862,225
Income Tax Expense/Benefit 1,505 1,011 1,675 3,754
Interest Expense, Operating UNPUB UNPUB UNPUB 454
Net Income/Loss -3,382 -3,199 -2,836 -10,865,979
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,382 -3,199 -2,836 -10,865,979
Net Income/Loss Available To Common Stockholders, Basic -3,382 -3,199 -2,836 -10,865,979
Operating Expenses 3,392 3,205 2,845 10,881,834
Operating Income/Loss -3,391,575 -3,204,757 -2,844,745 -10,881,834
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-11 2015-07-30 2015-10-29 2016-02-25
Assets 25,467,843 24,719,397 39,587,069 37,906,323
Current Assets 10,337,491 9,602,063 24,344,784 22,726,206
Current Liabilities 853,029 1,106,943 1,296,530 1,490,506
Equity 20,946,331 19,945,313 34,625,804 32,752,974
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 20,946,331 19,945,313 34,625,804 32,752,974
Liabilities 4,521,512 4,774,084 4,961,265 5,153,349
Liabilities And Equity 25,467,843 24,719,397 39,587,069 37,906,323
Noncurrent Assets 15,130,352 15,117,334 15,242,285 15,180,117
Noncurrent Liabilities 3,668,483 3,667,141 3,664,735 3,662,843
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-11 2015-07-30 2015-10-29 2016-02-25
Exchange Gains/Losses -616 -1,102 964 -1,748
Net Cash Flow -2,595,986 -492,642 15,031,465 10,407,314
Net Cash Flow, Continuing -2,595,370 -491,540 15,030,501 10,409,062
Net Cash Flow From Financing Activities 638,146 741,120 16,202,403 17,563,752
Net Cash Flow From Financing Activities, Continuing 638,146 741,120 16,202,403 17,563,752
Net Cash Flow From Investing Activities -616 -1,102 -602 -2,320
Net Cash Flow From Investing Activities, Continuing -616 -1,102 -602 -2,320
Net Cash Flow From Operating Activities -3,233,516 -1,232,660 -1,169,582 -7,152,370
Net Cash Flow From Operating Activities, Continuing -3,233,516 -1,232,660 -1,169,582 -7,152,370
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-11 2015-07-30 2015-10-29 2016-02-25
Comprehensive Income/Loss -2,215 -2,287 -1,608 -8,846,867
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,215,708 -2,288,503 -1,606,057 -8,846,867
Other Comprehensive Income/Loss 0 0 0 -8,846,867
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-11 2015-07-30 2015-10-29 2016-02-25
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,215 -2,287 -1,608 -8,845,079
Income/Loss From Continuing Operations Before Tax -2,212,117 -2,285,161 -1,606,507 -8,837,720
Income Tax Expense/Benefit 2,946 1,661 1,383 7,359
Interest Expense, Operating 140 UNPUB UNPUB 514
Net Income/Loss -2,215 -2,287 -1,608 -8,845,079
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,215 -2,287 -1,608 -8,845,079
Net Income/Loss Available To Common Stockholders, Basic -2,215 -2,287 -1,608 -8,845,079
Operating Expenses 2,215 2,277 1,594 8,822,386
Operating Income/Loss -2,214,955 -2,277,128 -1,594,133 -8,822,386
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-08 2014-08-13 2014-11-13 2015-03-12
Assets 31,217,204 29,564,076 27,787,306 27,273,494
Current Assets 16,061,879 14,404,508 12,630,879 12,132,921
Current Liabilities 901,816 1,096,403 1,134,790 1,593,994
Equity 26,649,897 24,800,873 22,984,657 22,010,589
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 26,649,897 24,800,873 22,984,657 22,010,589
Liabilities 4,567,307 4,763,203 4,802,649 5,262,905
Liabilities And Equity 31,217,204 29,564,076 27,787,306 27,273,494
Noncurrent Assets 15,155,325 15,159,568 15,156,427 15,140,573
Noncurrent Liabilities 3,665,491 3,666,800 3,667,859 3,668,911
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-08 2014-08-13 2014-11-13 2015-03-12
Exchange Gains/Losses 113 -254 -2,011 -6,325
Net Cash Flow 8,083,848 -1,287,754 -1,559,687 4,968,942
Net Cash Flow, Continuing 8,083,735 -1,287,500 -1,557,676 4,975,267
Net Cash Flow From Financing Activities 3,318,838 40,626 33,319 4,162,261
Net Cash Flow From Financing Activities, Continuing 3,318,838 40,626 33,319 4,162,261
Net Cash Flow From Investing Activities -3,523 0 0 -3,523
Net Cash Flow From Investing Activities, Continuing -3,523 0 0 -3,523
Net Cash Flow From Operating Activities 4,768,420 -1,328,126 -1,590,995 816,529
Net Cash Flow From Operating Activities, Continuing 4,768,420 -1,328,126 -1,590,995 816,529
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-08 2014-08-13 2014-11-13 2015-03-12
Comprehensive Income/Loss -2,352,000 -2,122,000 -2,340,000 -9,215,466
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,349,796 -2,120,971 -2,347,210 -9,215,466
Other Comprehensive Income/Loss 0 0 0 -9,215,466
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-08 2014-08-13 2014-11-13 2015-03-12
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,352,000 -2,122,000 -2,340,000 -9,195,292
Income/Loss From Continuing Operations Before Tax -2,350,922 -2,120,221 -2,338,769 -9,199,264
Income Tax Expense/Benefit 1,543 1,547 1,472 -3,972
Interest Expense, Operating 123 181 173 628
Net Income/Loss -2,352,000 -2,122,000 -2,340,000 -9,195,292
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,352,000 -2,122,000 -2,340,000 -9,195,292
Net Income/Loss Available To Common Stockholders, Basic -2,352,000 -2,122,000 -2,340,000 -9,195,292
Operating Expenses 2,364,000 2,131,000 2,345,000 9,223,011
Operating Income/Loss -2,363,733 -2,131,041 -2,345,259 -9,223,011
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-08 2013-08-08 2013-11-07 2014-03-27
Assets 18,845,713 27,676,769 26,196,620 29,546,243
Current Assets 3,712,646 12,497,641 11,039,097 14,382,606
Current Liabilities 948,150 1,075,633 1,099,404 460,435
Equity 14,247,400 22,950,973 21,447,053 25,425,756
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 14,247,400 22,950,973 21,447,053 25,425,756
Liabilities 4,598,313 4,725,796 4,749,567 4,120,487
Liabilities And Equity 18,845,713 27,676,769 26,196,620 29,546,243
Noncurrent Assets 15,133,067 15,179,128 15,157,523 15,163,637
Noncurrent Liabilities 3,650,163 3,650,163 3,650,163 3,660,052
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-08 2013-08-08 2013-11-07 2014-03-27
Exchange Gains/Losses UNPUB UNPUB UNPUB 2,479
Net Cash Flow -981,466 8,988,416 -1,356,631 2,689,963
Net Cash Flow, Continuing -981,466 8,988,416 -1,356,631 2,687,484
Net Cash Flow From Financing Activities 1,635,635 11,129,739 534,277 13,370,694
Net Cash Flow From Financing Activities, Continuing 1,635,635 11,129,739 534,277 13,370,694
Net Cash Flow From Investing Activities 4,800 -44,322 15,008 -36,754
Net Cash Flow From Investing Activities, Continuing 4,800 -44,322 15,008 -36,754
Net Cash Flow From Operating Activities -2,621,901 -2,097,001 -1,905,916 -10,646,456
Net Cash Flow From Operating Activities, Continuing -2,621,901 -2,097,001 -1,905,916 -10,646,456
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-08 2013-08-08 2013-11-07 2014-03-27
Comprehensive Income/Loss -2,425,927 -2,786,000 -2,237,000 -4,041,374
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,419,000 -2,789,753 -2,235,994 -4,041,374
Other Comprehensive Income/Loss 0 0 0 -4,041,374
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-08 2013-08-08 2013-11-07 2014-03-27
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 0 5,207,756 2,234,944 4,027,750
Cost Of Revenue UNPUB 0 0 UNPUB
Costs And Expenses 2,421,000 2,786,756 2,234,944 4,027,750
Diluted Earnings Per Share 0 0 0 0
Gross Profit UNPUB 0 0 UNPUB
Income/Loss From Continuing Operations After Tax -2,419,000 -2,786,000 -2,237,000 -4,028,528
Income/Loss From Continuing Operations Before Tax -2,420,259 -2,784,240 -2,234,944 -4,024,493
Income Tax Expense/Benefit -1,245 1,789 1,806 4,035
Interest Expense, Operating UNPUB 0 0 UNPUB
Net Income/Loss -2,419,000 -2,786,000 -2,237,000 -4,028,528
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,419,000 -2,786,000 -2,237,000 -4,028,528
Net Income/Loss Available To Common Stockholders, Basic -2,419,000 -2,786,000 -2,237,000 -4,028,528
Operating Expenses 2,421,000 2,788,000 2,242,000 10,023,797
Operating Income/Loss -2,417,294 -2,788,197 -2,242,347 -4,020,540
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 3,000 0 0 3,257
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Assets UNPUB UNPUB UNPUB 19,568,041
Current Assets UNPUB UNPUB UNPUB 4,422,122
Current Liabilities UNPUB UNPUB UNPUB 1,037,792
Equity UNPUB UNPUB UNPUB 14,879,992
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 14,879,992
Liabilities UNPUB UNPUB UNPUB 4,688,049
Liabilities And Equity UNPUB UNPUB UNPUB 19,568,041
Noncurrent Assets UNPUB UNPUB UNPUB 15,145,919
Noncurrent Liabilities UNPUB UNPUB UNPUB 3,650,257
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB -11,082,594
Net Cash Flow, Continuing UNPUB UNPUB UNPUB -11,082,594
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 1,545,222
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 1,545,222
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -763,378
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -763,378
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -11,864,438
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -11,864,438
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Comprehensive Income/Loss UNPUB UNPUB UNPUB -10,972,426
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -10,972,426
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB -11,112
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 11,752,750
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 11,752,750
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -10,961,314
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB -10,950,170
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 11,144
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB UNPUB UNPUB -10,961,314
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -10,961,314
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -10,961,314
Operating Expenses UNPUB UNPUB UNPUB 11,747,936
Operating Income/Loss UNPUB UNPUB UNPUB -10,945,356
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 802,580
Calendar
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:MNOV240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:MNOV240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:MNOV240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:MNOV240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:MNOV240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:MNOV240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:MNOV240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:MNOV240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:MNOV240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:MNOV240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:MNOV240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:MNOV240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:MNOV240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:MNOV240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:MNOV240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:MNOV240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:MNOV240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:MNOV240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:MNOV240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:MNOV240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:MNOV240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:MNOV240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:MNOV240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:MNOV240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:MNOV240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:MNOV240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:MNOV240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:MNOV240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:MNOV240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:MNOV240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:MNOV231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:MNOV231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:MNOV231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:MNOV231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:MNOV231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:MNOV231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:MNOV231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:MNOV231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:MNOV231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:MNOV231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:MNOV231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:MNOV231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:MNOV231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:MNOV231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:MNOV231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:MNOV231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:MNOV231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:MNOV231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:MNOV230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:MNOV230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:MNOV230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:MNOV230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:MNOV230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:MNOV230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:MNOV230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:MNOV230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:MNOV230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:MNOV230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:MNOV230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:MNOV230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Stocks Patents
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome
LA JOLLA, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of chlorine-induced acute respiratory distress syndrome (ARDS).
GlobeNewswire Inc. • 5d ago
Health Health
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast)
LA JOLLA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received an issue notification from the U.S. Patent and Trademark Office for a new patent which covers extended-release oral formulations of MN-166 (ibudilast). This new patent is expected to expire no earlier than September 2040. The allowed claims cover a formulation in the form of a tablet or capsule and cover a range of doses of MN-166 (ibudilast).
GlobeNewswire Inc. • 1w ago
Calendar Calendar of Events
MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)
LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding results of a clinical trial of MN-166 (ibudilast) in glioblastoma (GBM) has been selected for an oral presentation at the American Society of Clinical Oncology (2024 ASCO) Annual Meeting to be held May 31 – June 4, 2024 in Chicago. The oral presentation will be presented by one of the investigators of this clinical trial, Gilbert Youssef, M.D., Attending Physician at Harvard Medical School, Center for Neuro-Oncology at Dana-Farber Cancer Institute and Brigham and Women's Hospital.
GlobeNewswire Inc. • 1mo ago
stocks Patents
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of macular injury associated with progressive multiple sclerosis.
GlobeNewswire Inc. • 1mo ago
Stocks Patents
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of macular injury associated with progressive multiple sclerosis.
GlobeNewswire Inc. • 1mo ago
News Product / Services Announcement
MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society
LA JOLLA, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that two abstracts entitled “STUDY PROTOCOL TO EVALUATE MN-001’S (TIPELUKAST) EFFICACY, SAFETY AND TOLERABILITY IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), HYPERTRIGLYCERIDEMIA (HTG) AND TYPE-2 DIABETES MELLITUS (T2DM)” and “MN-002, THE METABOLITE OF MN-001(TIPELUKAST) PROMOTES MACROPHAGE CHOLESTEROL EFFLUX” have been accepted and selected for poster presentation at the 92nd European Atherosclerosis Society (EAS) 2024 Congress to be held May 26-29, 2024.
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology
LA JOLLA, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova’s collaborator, Perenlei Enkhbaatar, MD, PhD, FAHA, Professor, Department of Anesthesiology, Director, Translational Intensive Care Unit, Charles Robert Allen Professor in Anesthesiology, University of Texas Medical Branch, presented new data and results of a nonclinical study evaluating MN-166 (ibudilast) in a chlorine gas-induced acute lung injury (CIALI) model at the Society of Toxicology (SOT) 63rd Annual Meeting and ToxExpo in Salt Lake City, Utah.
GlobeNewswire Inc. • 2mo ago
Stocks Patents
MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China
LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Grant from the Chinese Patent Office for a new patent which covers MN-166 (ibudilast) for the treatment of macular injury associated with progressive multiple sclerosis.
GlobeNewswire Inc. • 4mo ago
Calendar Calendar of Events
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology
LA JOLLA, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding results of a nonclinical study of MN-166 (ibudilast) in chlorine gas-induced acute lung injury has been selected for a poster presentation at the Society of Toxicology (SOT) 63rd Annual Meeting and ToxExpo to be held March 10 - 14, 2024 in Salt Lake City, Utah. The poster will be presented by MediciNova’s collaborator, Perenlei Enkhbaatar, MD, PhD, FAHA, Professor, Department of Anesthesiology, Director, Translational Intensive Care Unit, Charles Robert Allen Professor in Anesthesiology at The University of Texas Medical Branch.
GlobeNewswire Inc. • 4mo ago
Stocks Patents
MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe
LA JOLLA, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Decision to Grant from the European Patent Office for a pending patent application which covers the combination of MN-166 (ibudilast) and interferon-beta for the treatment of progressive multiple sclerosis (progressive MS).
GlobeNewswire Inc. • 5mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT